Gastric cancer (GC) is a highly malignant disease affecting humans worldwide and has a
poor prognosis. Most GC cases are detected at advanced stages due to the cancer lacking …

Gastric cancer is an aggressive and multifactorial disease. Helicobacter pylori (H. pylori) is
identified as a significant etiological factor in gastric cancer. Although only a fraction of …

The epigenetic regulation of N6-methyladenosine (m6A) has attracted considerable interest
in tumor research, but the potential roles of m6A regulator-related genes, remain largely …

Gastric cancer represents a significant global health challenge with elevated incidence and
mortality rates, highlighting the need for advancements in diagnostic and therapeutic …

Gastric cancer (GC) is the fourth leading cause of death worldwide, with more than 1 million
cases diagnosed every year. Helicobacter pylori represents the main risk factor, being …

Background As one of the most prevalent cancers, gastric cancer (GC) exhibits a remarkably
high morbidity and mortality rate. To date, effective diagnostic and prognostic markers and …

Exhaled breath analysis, with particular emphasis on volatile organic compounds,
represents a growing area of clinical research due to its obvious advantages over other …

Precancerous lesions of gastric cancer (PLGC) represent a critical pathological stage in the
transformation from normal gastric mucosa to gastric cancer (GC). The global incidence of …

Ethnopharmacological relevance Chronic atrophic gastritis (CAG), precancerous lesions of
gastric cancer (PLGC), and gastric cancer (GC), seriously threaten human health. Traditional …

Gastric cancer is the fifth leading cause of cancer-related deaths worldwide. As the
diagnosis of early gastric cancer is difficult, most patients are at a late stage of cancer …